Page last updated: 2024-10-24

chloroquine and Diathesis

chloroquine has been researched along with Diathesis in 14 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Between 1998 and 2001, Kenya, Uganda, Tanzania, Zanzibar, Rwanda and Burundi changed antimalarial drug policy, in the face of widespread chloroquine resistance."7.72The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. ( , 2003)
"Fluconazole alone was not found significantly effective against C."5.32Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. ( Jabeen, R; Khan, MA; Mohammad, O, 2004)
"Between 1998 and 2001, Kenya, Uganda, Tanzania, Zanzibar, Rwanda and Burundi changed antimalarial drug policy, in the face of widespread chloroquine resistance."3.72The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. ( , 2003)
"To evaluate the susceptibility to coronavirus disease 2019 (COVID-19) in patients with autoimmune conditions treated with antimalarials in a population-based study."1.62Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy. ( Bajocchi, G; Boiardi, L; Carrozzi, G; Cassone, G; Costantini, M; Croci, S; Galli, E; Giorgi Rossi, P; Gradellini, F; Mancuso, P; Marata, AM; Muratore, F; Pandolfi, P; Pipitone, N; Reta, M; Salvarani, C; Sandri, G; Viani, N, 2021)
"Fluconazole alone was not found significantly effective against C."1.32Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole. ( Jabeen, R; Khan, MA; Mohammad, O, 2004)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19903 (21.43)18.7374
1990's3 (21.43)18.2507
2000's4 (28.57)29.6817
2010's1 (7.14)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Zhao, X1
Jiang, Y1
Zhao, Y1
Xi, H1
Liu, C1
Qu, F1
Feng, X1
Osama El-Gendy, A1
Saeed, H1
Ali, AMA1
Zawbaa, HM1
Gomaa, D1
Harb, HS1
Madney, YM1
Osama, H1
Abdelrahman, MA1
Abdelrahim, MEA1
Salvarani, C1
Mancuso, P1
Gradellini, F1
Viani, N1
Pandolfi, P1
Reta, M1
Carrozzi, G1
Sandri, G1
Bajocchi, G1
Galli, E1
Muratore, F1
Boiardi, L1
Pipitone, N1
Cassone, G1
Croci, S1
Marata, AM1
Costantini, M1
Giorgi Rossi, P1
McLean, ARD1
Boel, M1
McGready, R1
Ataide, R1
Drew, D1
Tsuboi, T1
Beeson, JG1
Nosten, F1
Simpson, JA1
Fowkes, FJI1
SWARTZWELDER, JC1
MULE, JG1
FRYE, WW1
VELLA, F1
Khan, MA1
Jabeen, R1
Mohammad, O1
Hatabu, T1
Kawazu, S1
Kojima, S1
Sato, K1
Singhasivanon, P1
Looareesuwan, S1
Kano, S1
Zipris, D1
Lien, E1
Nair, A1
Xie, JX1
Greiner, DL1
Mordes, JP1
Rossini, AA1
Stokes, WS1
Donovan, JC1
Montrey, RD1
Thompson, WL1
Wannemacher, RW1
Rozmiarek, H1
Blasi, E1
Barluzzi, R1
Mazzolla, R1
Bistoni, F1
Fryauff, DJ1
Baird, JK1
Awalludin, M1
Jones, T1
Subianto, B1
Richie, TL1
Tjitra, E1
Wignall, FS1
Hoffman, SL1
Collins, WE1
Skinner, JC1
Broderson, JR1
Filipski, VK1
Morris, CM1
Stanfill, PS1
Warren, M1
Vespa, L1
Zwilling, BS1

Reviews

1 review available for chloroquine and Diathesis

ArticleYear
Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:7

    Topics: Angiotensin-Converting Enzyme 2; Anti-Inflammatory Agents; Antimalarials; Antiviral Agents; Basal Me

2020

Trials

1 trial available for chloroquine and Diathesis

ArticleYear
Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis.
    The American journal of tropical medicine and hygiene, 1997, Volume: 56, Issue:2

    Topics: Antimalarials; Chloroquine; Disease Susceptibility; Follow-Up Studies; Humans; Incidence; Indonesia;

1997

Other Studies

12 other studies available for chloroquine and Diathesis

ArticleYear
Bacillus Calmette-Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality.
    Vaccine, 2020, 07-31, Volume: 38, Issue:35

    Topics: Aging; Antiviral Agents; BCG Vaccine; Chemoprevention; Chloroquine; Coronavirus Infections; COVID-19

2020
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.
    Arthritis & rheumatology (Hoboken, N.J.), 2021, Volume: 73, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antimalarials; Antirheumatic Agents; Arthritis, Juvenile; Arthritis,

2021
Antibody Responses to
    The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5

    Topics: Adaptive Immunity; Antibodies, Protozoan; Antimalarials; Artemisinins; Artesunate; Chloroquine; Coho

2017
Trichomonas vaginalis infection; evaluation of the susceptibility to systemic medication.
    Medical times, 1955, Volume: 83, Issue:7

    Topics: Chloroquine; Disease; Disease Susceptibility; Female; Humans; Trichomonas Infections; Trichomonas va

1955
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy.
    Tropical medicine & international health : TM & IH, 2003, Volume: 8, Issue:10

    Topics: Africa, Eastern; Amodiaquine; Antimalarials; Chloroquine; Disease Susceptibility; Drug Combinations;

2003
Prophylactic role of liposomized chloroquine against murine cryptococcosis less susceptible to fluconazole.
    Pharmaceutical research, 2004, Volume: 21, Issue:12

    Topics: Animals; Cell Line; Chloroquine; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Di

2004
In vitro susceptibility and genetic variations for chloroquine and mefloquine in Plasmodium falciparum isolates from Thai-Myanmar border.
    The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36 Suppl 4

    Topics: Animals; Chloroquine; Disease Susceptibility; Drug Resistance, Microbial; Genetic Variation; Humans;

2005
TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Jan-15, Volume: 178, Issue:2

    Topics: Animals; B-Lymphocytes; Breeding; Cells, Cultured; Chloroquine; Diabetes Mellitus, Type 1; Disease S

2007
Acute clinical malaria (Plasmodium inui) in a cynomolgus monkey (Macaca fascicularis).
    Laboratory animal science, 1983, Volume: 33, Issue:1

    Topics: Acute Disease; Animal Population Groups; Animals; Animals, Wild; Antimalarials; Chloroquine; Disease

1983
Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans.
    Infection and immunity, 1993, Volume: 61, Issue:8

    Topics: Animals; Brain Diseases; Candidiasis; Chloroquine; Colchicine; Cryptococcosis; Disease Susceptibilit

1993
Susceptibility of Macaca fascicularis monkeys from Mauritius to different species of Plasmodium.
    The Journal of parasitology, 1992, Volume: 78, Issue:3

    Topics: Animals; Chloroquine; Disease Susceptibility; Drug Therapy, Combination; Macaca fascicularis; Malari

1992
Expression of I-A by macrophages from Bcgr and Bcgs mice. Transient expression of I-A is due to degradation of MHC class II glycoproteins.
    Journal of immunology (Baltimore, Md. : 1950), 1989, Jul-01, Volume: 143, Issue:1

    Topics: Animals; Chloroquine; Disease Susceptibility; Glycoproteins; Histocompatibility Antigens Class II; I

1989